Freedom Biosciences Raises $10.5M in Seed Financing

Freedom Biosciences, a San Francisco, CA-based supplier of a clinical-stage biotechnology platform to advance ketamine and psychedelic therapeutics, raised $10.5M in Seed funding.

The spherical was led by MBX Capital with participation from PsyMed Ventures, Village International and The Yale Startup.

The corporate intends to make use of the funds to advance its present lead ketamine program in addition to additional a number of extra exploratory packages.

Co-founded in April 2021 by Dr. John Krystal, Chair of the Division of Psychiatry at Yale College, and Dina Burkitbayeva, founding father of PsyMed Ventures, alongside Hunter Bouchard and Morgan Springer, Freedom Biosciences is a clinical-stage biotechnology platform growing viable and efficacious ketamine and psychedelic therapeutics.

The corporate’s FREE001 is a ketamine therapy that’s been demonstrated in medical trials to have extra sturdy results than ketamine. A Part 2 investigational research confirmed that the mixture offered 14 days of antidepressant results, 2 to three instances longer than the standard 2-7 days of results from ketamine alone. This prolonged efficacy has extraordinarily promising implications for the therapy’s accessibility for sufferers who’re unable to make frequent visits to a clinic.

Key members of the Freedom Biosciences workforce additionally embrace Robert Berman, M.D., who serves because the Head of the Scientific Advisory Board and Senior Medical Advisor. Inaugural members of Freedom Biosciences Scientific and Strategic Advisory Board additionally embrace:

  • Dr. Zubin Bhagwagar, International Program Lead at RallyBio with 25+ years of educational and business expertise in biopharma
  • Dr. Robin Carhart-Harris, founding father of the Heart for Psychedelic Analysis at Imperial Faculty London, has designed human mind imaging research with LSD, psilocybin, MDMA and DMT, and medical trials of psilocybin remedy for extreme psychological diseases
  • Dr. Victoria Hale, former Chair of the Board of Administrators at Multidisciplinary Affiliation for Psychedelic Research (MAPS) and co-founder and former CEO of Medicines360
  • Dr. Alex Kwan, Affiliate Professor within the Meinig Faculty of Biomedical Engineering at Cornell College
  • Dr. Tom Laughren, former Division Director for the Division of Psychiatry Merchandise, Heart for Drug Analysis and Analysis at FDA
  • Dr. Kurt Rasmussen, Chief Scientific Officer at Delix Therapeutics and former Head of Division of Therapeutics & Medical Penalties at Nationwide Institute on Drug Abuse (NIDA)
  • Dr. Gerard Sanacora, Director of Yale Melancholy Analysis Program and Co-Director of Yale New Haven Hospital Intervention Psychiatry Service

Freedom Biosciences Raises $10.5M in Seed Financing.Congratulations to the entire team. I wish you great success in this endeavour.

Shishir Gupta, Founder and CEO, StartupLanes

Don’t keep wondering about funding, you can also raise funds. Learn how to raise funds here: Yes I want to raise funds.

If you are an emerging startup and are looking for investors to raise funds, StartupLanes has its own angel network and investment banking services and is connected to angel investors and VCs in 15 countries that ensure that our member startups have easy access to external funds to scale up constantly.

You can subscribe to our news posts by entering your email in the box on the right side of this page.

Check out our YouTube channel for insightful content from the Indian startup ecosystem.

Or join our Whatsapp group to interact with other founders: Yes, I want to join the Whatsapp group.

The right investment is key to beating inflation and growing your wealth. Do you wish to become an angel investor? Yes, I want to be an angel investor.

Are you a startup and facing challenges in your business? Do you want to grow your business? It is not as difficult as it sounds. Learn how to grow your business here- Yes, I want to grow my business. For any rectifications, reach out to ashu@startuplanes.com